I confirm I am a UK Healthcare Professional (HCP)
This page is dedicated to UK HCPs only. If you are not a UK HCP, you will be directed to the Homepage after clicking on No.
Our VAM Portfolio
Our Value-Added Medicines provide a unique presentation or formulation of an existing molecule
The development of Value-Added Medicines (VAMs) is driven by the need to address specific patient requirements and improve overall healthcare outcomes.
Half doses to eliminate need for tablet splitting
Soluble and liquid forms for patients with swallowing difficulties
Double strength to reduce the pill burden for patients
New strengths for dosage titration
Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Zentiva via email to UKMedInfo@zentiva.com
or via phone on 0800 090 2408.